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Abstract 
Adherence to dietary guidelines may result in higher intakes of polyphenols via increased 
consumption of fruits, vegetables and whole grains. We compared polyphenol dietary 
intakes and urinary excretion between two intervention groups in the CRESSIDA study: a 
12-week, parallel-arm, randomised controlled trial (n=161; 64 M, 97 F; aged 40-70 y). One 
group adhered to UK dietary guidelines (DG) whereas the other group consumed a 
representative UK diet (control). We estimated polyphenol dietary intakes, using 4-day 
food diaries (4-DFD) and food frequency questionnaires (FFQ), and analysed twenty-four 
hour polyphenol urinary excretion by LC-MS/MS on a subset of participants (n=46 control; 
n=45 DG). A polyphenol food composition database for 4-DFD analysis was generated 
using Phenol-Explorer and USDA databases. Total polyphenol intakes by 4-DFD at 
endpoint (geometric means with 95% CI, adjusted for baseline and gender) were 
significantly higher in the DG group (1279 mg/d/10 MJ; 1158, 1412) compared to the 
control group (1084 mg/d/10 MJ; 980, 1197). The greater total polyphenol intakes in the 
DG group were attributed to higher intakes of anthocyanidins, proanthocyanidins and 
hydroxycinnamic acids, with the primary food sources being fruits, cereal products, nuts 
and seeds. FFQ estimates of flavonoid intakes also detected greater intakes in DG 
compared with the control group. Twenty-four hour urinary excretion showed consistency 
with 4-DFD in their ability to discriminate between dietary intervention groups for 6 out of 
10 selected, individual polyphenols. In conclusion, following UK dietary guidelines 
increased total polyphenol intakes by approximately 20%, but not all polyphenol subclasses 
corresponded with this finding.  
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Introduction  1 
Greater consumption of fruit and vegetables and whole grains is associated with reduced risk of chronic 2 
diseases(1, 2, 3, 4, 5). Increased intakes of different components present in these food groups, like fibre(6), 3 
micronutrients(7) and polyphenols(8), have been identified as being partly responsible for beneficial 4 
effects. However, results from the UK National Diet and Nutrition Survey (NDNS ) rolling 5 
programme(9, 10, 11) reveal that consumption of fruit and vegetables and whole grains is below 6 
recommended intakes in  at least 70% of the UK adult population (9, 10, 11, 12). Dietary polyphenols are a 7 
diverse range of phytochemicals containing 1 or more aromatic rings attached to a hydroxyl group. The 8 
term “polyphenol” commonly encompasses phenolic acids, flavonoids, stilbenes and lignans, which are 9 
derived from a wide range of plant foods including fruits, vegetables, and cereals. However, beverages 10 
such as tea, coffee, red wine, and fruit juices represent the main dietary sources(13). Epidemiological 11 
studies have shown a negative relationship between consumption of polyphenols and cardiovascular 12 
disease(14, 15, 16, 17, 18), cancer(19, 20, 21, 22) and type 2 diabetes (18, 23, 24, 25, 26). Multiple mechanisms have 13 
been identified that may contribute to any direct causal relationship between dietary polyphenols and 14 
prevention of chronic diseases, including modulating inflammatory pathways, exerting effects on 15 
oxidative signalling and enzyme activity, and regulation of gene expression(8). 16 
 
Previous reports in UK populations, using either 24 h recall(27, 28, 29, 30, 31) or food diaries(27, 28, 29, 30, 31) , 17 
suggest that habitual polyphenol intakes are in the range of 800-1600 mg/d, depending on the 18 
population studied. However, the use of different dietary assessment methods, food polyphenol 19 
composition databases, and gaps in polyphenol composition data for certain foods limit the reliability 20 
of current intake estimates in various countries(32) . Food diaries may provide a relatively accurate 21 
estimate of polyphenol intake and are more suitable for dietary intervention studies with smaller study 22 
populations, but they reflect short-term intakes rather than habitual consumption patterns, which could 23 
be particularly misleading for seasonally available foods(33). Research groups have designed and 24 
validated FFQs to estimate dietary flavonoid intake in different populations(34, 35), which may provide 25 
more reliable habitual intake estimations for specific populations. However, these remain unavoidably 26 
susceptible to bias due to self-reporting errors, portion size quantification and estimation errors 27 
resulting from the lack of data on polyphenol content in food (36). Whichever dietary assessment 28 
method is selected, the resulting intake data will only be accurate if the polyphenol composition of 29 
foods database is fit for purpose. At present, the most commonly used food polyphenol composition 30 
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databases are Phenol-Explorer(37, 38, 39), which provides information on the content of 502 polyphenols 31 
(of the 4 classes) in 459 food items including aglycones, glycosides, and esters, and the USDA 32 
databases(40, 41, 42) which includes 35 flavonoids (aglycones only) in 506 food items, respectively. 33 
Urinary excretion of polyphenols has been shown to be a suitable biomarker for the intake of 34 
polyphenols(43, 44), fruit and vegetables(45, 46), polyphenol-rich beverages(47, 48) and polyphenol-rich 35 
food(49, 50). The presence of polyphenol metabolites in urine is closely related to the quantity consumed 36 
and overall metabolism in the body. However, different polyphenols can produce common metabolites 37 
and so the biomarker selected must reflect the specific intake of the parent polyphenol in question in 38 
order to accurately estimate intakes of individual phenolic compounds(51). 39 
   
Dietary guidelines in the UK are population-based recommendations for maintenance of health and 40 
wellbeing, and to reduce risk of chronic diseases. No dietary recommendations exist for polyphenols, 41 
although the advantages and disadvantages of this approach have been debated(52, 53, 54). A dietary 42 
pattern consistent with current dietary guidelines could reasonably be assumed to be richer in 43 
polyphenols than the average UK dietary pattern due to increased intakes of fruit and vegetables and 44 
whole grains. However, not all fruits and vegetables are polyphenol-rich(55), and in fact the majority of 45 
dietary polyphenols in the UK are provided by tea, coffee, and cocoa intakes(30). The aim of this study 46 
was to compare dietary polyphenol intakes in a free-living study population randomised to either 47 
following UK dietary guidelines, or consuming a representative, more traditional UK diet. The 48 
hypothesis was that adherence to UK dietary guidelines would result in an increase in total dietary 49 
polyphenol intakes compared with a diet that was more representative of the UK adult population. The 50 
primary outcome variable was total polyphenol intake, adjusted for energy intake, assessed by 4-day 51 
food diary. Secondary outcome variables included intakes of classes, subclasses and individual 52 
phenolic acids/polyphenols. Data were also compared with FFQ(15), and biomarkers of polyphenol 53 
intake (24 h excretion of representative urinary metabolites). 54 
Methods 55 
Study design  56 
The Cardiovascular risk REduction Study: Supported by an Integrated Dietary Approach (CRESSIDA) 57 
was a 12-week parallel-designed, randomised, controlled trial funded by the Food Standards 58 
Agency/Department of Health (UK) (N02047), sponsored by King’s College London. This study was 59 
conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures 60 
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involving human subjects were approved by the St. Thomas' Hospital Research Ethics Committee 61 
(10/H0802/24)(56). Written informed consent was obtained from all subjects. This trial was registered at 62 
Current Controlled Trial (http://www.controlled-trials.com/ISRCTN) as ISRCTN92382106. The 63 
primary aim of the original study(56) was to assess effects on CVD risk factors when following a diet 64 
based on UK dietary guidelines (DG) in comparison to a representative UK diet (control). A sample 65 
size of 78/group had 90% power to detect a 4 mm Hg effect of diet on daytime systolic ambulatory 66 
blood pressure (alpha 0.05); this sample size was also large enough to detect a 5% change in the ratio 67 
of total cholesterol (TC):HDL cholesterol and a 1% unit change in flow-mediated dilatation of the 68 
brachial artery with sufficient statistical power. The results of these primary outcomes have been 69 
published previously(56).   70 
The data presented here comprises a secondary analysis of dietary intake data from both the DG and 71 
control groups at baseline and endpoint of the 12-week dietary intervention period, to determine 72 
whether adherence to UK dietary guidelines results in an increase in polyphenol intake. 73 
Participants    74 
Healthy men and women [BMI (in kg/m2) ≥18.5 and ≤35] were recruited from the London area 75 
(August 2010–July 2012) by newspaper (London Metro) and electronic advertisement (King’s College 76 
London e-mail and website). Participants between the age of 40-70 y were chosen because risk 77 
increases markedly with age and an upper age limit of 70 y was selected because absolute annual risk 78 
of CVD exceeds 2% beyond that age in the majority of people, and a higher proportion are receiving 79 
medication on daily basis. A full list of inclusion and exclusion criteria has been reported previously(56). 80 
For randomisation a purpose-designed clinical database was used (MedSciNet AB, Stockholm, 81 
Sweden), which undertook the minimisation randomisation, balancing the treatment arms for the 82 
minimisation variables of gender, age and ethnicity(56). Participants received dietary advice in person at 83 
baseline and at week 4, and by phone at week 6 and 8. Dietary assessment included two FFQ and two 84 
four-day food diaries (4-DFD) administered at baseline and endpoint and two 24-h recalls administered 85 
at weeks 4 and 8. Urine samples were collected at four time points; baseline, week 4, 8 and endpoint.  86 
Dietary advice 87 
Participants randomised to the DG group were advised to increase fruit and vegetables intake to 5 88 
portions/day; whole grains intake to >50% of cereal intake; to consume 2 portions of fish per week (1 89 
of which should be oily); to replace full-fat with reduced fat dairy products; to replace fats rich in 90 
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saturated fatty acids with spreads/oils low in saturated fatty acids and high in monounsaturated fatty 91 
acids; to restrict salt intake to <6 g/d (<100 mmol/d) and to reduce intake of free sugars. The control 92 
diet comprised a nutritionally balanced, traditional UK diet, formulated with familiar foods (full cream 93 
milk, cheese, butter, meat and meat products, non-wholegrain cereals), reflecting typical UK intakes of 94 
fruit and vegetables (3 portions/d), with a higher content of saturated fatty acids (14% energy), 95 
unrestricted intakes of salt and sugar, and low intakes of oily fish. The study included provision of 96 
spread, oil, whole grain pasta, rice and cereal bars, minimally processed wholegrain breakfast cereal 97 
(oats, muesli, etc.), almonds and macadamia nuts and tinned oily fish to the intervention group and 98 
spread, oil and refined cereals as pantry items to the control group. Participants of both groups were 99 
instructed to refrain from taking nutritional supplements during the study(57).  100 
Four-day food diary (4-DFD)  101 
Dietary intake of polyphenols was quantified from 4-DFD, at baseline and endpoint of the 12-wk 102 
intervention. A polyphenol food composition database was generated using Phenol-Explorer(37, 38, 39) 103 
and USDA databases(40, 41, 42), and extended using polyphenol retention factors and recipes provided by 104 
participants. If a recipe was not provided by a participant, a standard recipe was obtained from either 105 
the UK food tables(58), a UK food industry recipe book(59), the BBC Good Food website(60) or additional 106 
websites specialised in UK recipes and other countries’ typical cuisines. In total 118 recipes were 107 
obtained from participants, 93 from UK food tables, 20 from a UK food industry recipe book, 78 from 108 
the BBC Good Food website and 94 from other websites. Polyphenol intake was estimated for four 109 
classes of polyphenols: flavonoids, phenolic acids, lignans and stilbenes. An additional group of 110 
polyphenols were included under the name “other polyphenols”; since Phenol-Explorer grouped a 111 
series of compounds including alkylmethoxyphenols, alkylphenols, curcuminoids, furanocoumarins 112 
and tyrosols. The flavonoid intake was analysed in eight subclasses: anthocyanins, dihydrochalcones, 113 
flavanols (flavan-3-ols monomers and theaflavins), proanthocyanidins, flavanones, flavones, flavonols 114 
and isoflavones, for each subclass a range of 2 to 11 of the most representative individual compounds 115 
were selected. For phenolic acids subclass 2 groups were analysed: hydroxybenzoic acids and 116 
hydroxycinnamic acids, for each group a range of 4 to 6 of the most representative individual 117 
compounds were selected. For lignans subclass, 4 individual compounds were analysed: pinoresinol, 118 
lariciresinol, secoisolariciresinol and matairesinol. For stilbenes subclass, resveratrol was selected and 119 
analysed. A total of 52 individual polyphenols were analysed and 1141 food items were included in the 120 
final database.  121 
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Food frequency questionnaires (FFQ)  122 
Dietary intake of flavonoids was quantified from FFQ (EPIC-Norfolk FFQ v.6) (61) at baseline and 123 
endpoint of the 12-wk intervention. Flavonoid intake was estimated from 6 subclasses and most 124 
representative compounds for each: flavanones (hesperetin, naringenin, eriodictyol), anthocyanins 125 
(cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin), flavones (apigenin, luteolin), 126 
flavonols (quercetin, kaempferol, myricetin, isorhamnetin), flavan-3-ols (catechin, epicatechin, 127 
gallocatechin, epigallocatechin, epicatechin-3-gallate, epigallocatechin-3-gallate) and polymers 128 
(theaflavins, thearubigins and proanthocyanidins). In total 32 individual flavonoids were analysed 129 
using a database created and kindly provided by Dr Amy Jennings and Prof Aedin Cassidy at 130 
University of East Anglia(15) and modified for the requirements of the FFQ analysis, so that the 131 
flavonoid content of 130 food items were analysed. FFQ registers the frequency of consumption of 132 
specific foods, of standard portion size, in a month. There were nine answer options which varied from 133 
“never or less than once in a month” to “six or more per day”. To calculate the total intake of 134 
subclasses of flavonoids, frequencies were converted to daily portions and multiplied by flavonoid 135 
content in each specific food item; the results were summed for each subclass and for each participant.  136 
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 137 
Twenty-four hour urine collections were made as previously described(56), using boric acid as 138 
preservative(62) and aliquots stored at -80 o C until analysis. Completeness of urine collection was 139 
measured using recovery of para-aminobenzoic acid according to a standard protocol(63). LC-MS/MS 140 
analysis was only performed on endpoint urine samples, collected at week 12 of the intervention to 141 
coincide with dietary assessment by 4-DFD. A previously published protocol for polyphenol analysis in 142 
urine(47) was adapted and developed for the quantification of ten aglycone metabolites of polyphenols. 143 
A subsample of the CRESSIDA study was selected for the analysis; the selection was based on the fruit 144 
and vegetables (F&V) intake reported in the endpoint FFQ, subsample included participants in the 145 
control group reporting the lowest intakes of F&V, and participants in the intervention group reporting 146 
the highest intakes of F&V were analysed. Quantification of endpoint samples allowed the comparison 147 
between groups at the end of the dietary intervention; the aim was to detect greater amounts of 148 
polyphenols excreted in urine by participants who reported consuming the most polyphenols by FFQ 149 
compared to participants who reported consuming the least, and to determine agreement with food 150 
diary data. One or two of the most representative aglycones of different polyphenol subclasses were 151 
selected for quantification. Ten phenolic compounds were analysed; phloretin (dihydrochalcones), 152 
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epicatechin (flavan-3-ols), hesperetin and eriodictyol (flavanones), luteolin (flavones), quercetin 153 
(flavonols), daidzein (isoflavones), gallic and vanillic acid (phenolic acids) and enterolactone as a 154 
product of microbial metabolism of lignans in colon. The phenolic compounds selected for 155 
quantification have been suggested as suitable biomarkers of polyphenol intake(55) with a high recovery 156 
and good correlation with fruit and vegetable intakes when estimated by FFQ, 24-h recalls or food 157 
diaries(50). The major food sources of the ten phenolic compounds are fruit, vegetables and wholegrain 158 
products, or represent the main metabolites of parent glucosides present in the previously mentioned 159 
foods.  160 
Purified standards phloretin, epicatechin, eriodictyol, hesperetin, luteolin, daidzein, gallic and vanillic 161 
acids were obtained from Santa Cruz Biotechnology, Germany and quercetin, enterolactone and 162 
catechin-2, 3, 4-13C3 from Sigma-Aldrich, UK. Stock solutions were prepared for all the purified 163 
phenolic compounds, two milligrams of each of the ten purified compounds were diluted in one 164 
millilitre of methanol or dimethyl sulfoxide according to supplier specifications and one milligram of 165 
Catechin-2, 3, 4-13C3 (internal standard) in one millilitre of methanol. Stock solutions were stored at -40 166 
o C or -80 o C (internal standard). Enzyme β-glucuronidase/sulfatase (0.05 g) type H-5 from Helix 167 
Pomatia (Sigma-Aldrich, UK) was diluted in one millilitre of 0.2% sodium chloride solution to create a 168 
working solution of 50,000 units per millilitre; the enzyme solution was stored at -40 o C. Urine 169 
samples (250 l) were processed for hydrolysis of glucuronide and sulphated metabolites using a 170 
modified version of Ito et al. (47). Urine samples were acidified with acetic acid (20 l, 0.58 M) and 171 
incubated with 1300 units of β-glucoronidase/sulfatase and 300 ng of internal standard at 37 o C, 120 172 
rpm for 1.5 h. A liquid-liquid extraction with ethyl acetate was performed twice (400 l and 300 l). 173 
The two organic layers were pooled and evaporated to dryness under N2 then stored at -80 
o C for 1-4 174 
days until their reconstitution with 100 μl of 40% methanol immediately before injection. Analysis of 175 
urine samples was performed on a HPLC system Hewlett-Packard series 1100 binary pump, coupled to 176 
a triple quadrupole mass spectrometer, Micromass Quattro LC (Micromass, Limited), operating in 177 
negative electrospray ionization (ES-) mode, equipped with a Zorbax SB-C18 column (2.1 x 50mm, 178 
3.5mm, Agilent). Ionization and fragmentation were optimized for each polyphenol by direct infusion 179 
of a standard solution and specific values for collision energy parameters were identified for each 180 
polyphenol. Peak for each polyphenol identity was established by the parent and daughter ion pair peak 181 
and retention time. Solvents A (water with  0.1% v/v formic acid) and B (acetonitrile with 0.1% v/v 182 
formic acid) were run in a 95/5% proportion at a flow rate of 0.2 ml/min with the following gradient: 183 
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0–1 min, 5% solvent B; 1–4 min, increase solvent B from 5% to 10%; 4–5 min, increase solvent B 184 
from 10% to 90%, 5-5.2 min, decrease solvent B from 90% to 5%, 5.2-15 min isocratic for 9.8 min. 185 
Peak areas were plotted against the internal standard response. A good linearity (r2 0.970–0.990) was 186 
observed for all the polyphenols quantified except for luteolin (r2= 0.922). Samples were run in the 187 
same batch and chromatograms were processed automatically by MassLynx Mass Spectrometry 188 
Software (MASSLYNXTM version 3.5) using the same processing integrate parameters, peak-to-peak 189 
amplitude and peak detection. Intra-assay coefficients of variability were phloretin 7.5%, epicatechin 190 
6%, hesperetin 21.9%, eriodictyol 9.6%, luteolin 9.8%, quercetin 10.8%, daidzein 3.1%, gallic acid 191 
21.4%, vanillic acid 14.4% and enterolactone 5.1%. Final quantities of phenolics compounds were 192 
estimated after adjustment by urinary volume. Calibration curves were prepared by spiking HPLC-193 
grade water with 2.5, 5, 12.5, 25, 50, 100, 150, 200 and 250 μl of mixed polyphenols working solution 194 
and 100 μl of internal standard working solution, the calibration curve range was 5-500 ng/ml. Spiked 195 
HPLC-grade water samples were treated with enzyme and extracted with ethyl acetate as were the 196 
urine samples, spiked samples were injected in duplicate at each concentration level. Limits of 197 
quantification were established using the spiked samples for calibrations curves; minimum detected 198 
values were 5 ng/ml for phloretin, epicatechin, eriodictyol, hesperetin, luteolin, daidzein, gallic acid 199 
and vanillic acid and 10 ng/ml for quercetin and enterolactone.   200 
Statistical analysis  201 
Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) v.21. Four-202 
day food diary intake data(64) were expressed as weight of intake (g) per day per 10 MJ energy intake, 203 
in order to adjust for variability in total food intake between individuals over the 4 days, whereas FFQ 204 
data were expressed simply as weight of intake (g) per day. Normality of data distribution was 205 
evaluated visually by inspection of histograms and normal Q-Q plots. Non-normally distributed 206 
variables were natural log transformed prior to statistical analysis by parametric methods, or analysed 207 
by non-parametric methods where log transformation failed to yield a normal distribution. Independent 208 
sample t-tests were conducted to compare groups at baseline in order to verify that the polyphenol 209 
intakes of each treatment group were similar before the dietary intervention. Where data were normally 210 
distributed, one-way analysis of variance with gender as a fixed factor and baseline value as covariate 211 
(ANCOVA) was conducted to find differences between groups at endpoint. Where data could not be 212 
transformed to a normal distribution, a Mann-Whitney U test was conducted to find differences 213 
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between groups at endpoint. Correlation analyses on urinary and dietary polyphenols were conducted 214 
by two-tailed Spearman’s correlations.  215 
Results 216 
A total of 165 healthy men and women aged 40–70 years were recruited, and 162 completed the 217 
CRESSIDA study (64 M, 97 F) (Figure 1). Dietary intake of polyphenols was quantified from 322 x 4-218 
DFD (n=161) and from 322 FFQ (n=161) (EPIC-Norfolk FFQ v.6)(61) at baseline and endpoint of the 219 
12-wk intervention, one participant randomised to the DG group did not complete the collection of 220 
food diaries therefore was eliminated from the analysis. Urinary excretion of polyphenols was analysed 221 
in a subsample (n=91) of the CRESSIDA study, 45 samples from participants in the control group 222 
reporting the lowest intakes of F&V, and 46 samples from participants in the intervention group 223 
reporting the highest intakes of F&V.  224 
 
Characteristics of the whole CRESSIDA study population at baseline are shown in Table 1. Mean BMI 225 
was significantly higher in the control group. Intakes of wholegrain cereals, fruits and vegetables and 226 
dietary fibre were higher in the study population at baseline than those reported in a larger, 227 
representative UK population sample (11, 56). As reported previously, at endpoint urinary potassium 228 
excretion was 9 mmol/d greater in the DG group indicating higher consumption of fruit and vegetables. 229 
Reported wholegrain cereal intake was 81 g/d at endpoint in the DG group (mainly wheat, oats and 230 
rice) compared with 32 g/d in the control group, as confirmed by higher plasma alkylresorcinol 231 
concentrations, reflecting intakes of whole grains mainly from wheat, barley, and rye (56). 232 
 
Four-day food diary  233 
Median total polyphenol intake at baseline in the whole study population (with lower and upper limits 234 
of IQR) was 1183 mg/d (745, 1613), or 1282 mg/d per 10 MJ energy intake (896, 1838). As shown in 235 
Table 2, baseline intakes of total polyphenols were significantly higher in the DG group compared to 236 
the control group due to greater intakes of total flavonoids, the main contributor being total 237 
proanthocyanidins.  238 
At endpoint, total polyphenol intakes per 10 MJ energy intake, adjusted for gender and baseline 239 
polyphenol intake, were higher in the DG group than in the control group (Table 2). Analysis of 240 
intakes of polyphenol classes at endpoint (unadjusted for gender and baseline as non-parametric 241 
statistical analysis was necessary) demonstrated that the DG group had higher intakes of total 242 
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flavonoids (although also higher in DG at baseline), total lignans, phenolic acids, stilbenes, and “other 243 
polyphenols” compared to the control group. For the major flavonoid subclasses, the DG group 244 
reported higher intakes of anthocyanidins, proanthocyanidins (although these were also higher at 245 
baseline), and isoflavones, but not dihydrochalcones, flavanols, flavones or flavonols. For the major 246 
phenolic acids subclasses, the DG group reported higher intakes of hydroxycinnamic acids, but the 247 
trend for higher intakes of hydroxybenzoic acids was not statistically significant. 248 
For individual (poly)phenols, there were no differences between groups at baseline, but at endpoint the 249 
group following the DG diet reported higher intakes of a number of anthocyanidins including cyanidin, 250 
malvidin, peonidin and petunidin (P<0.05) compared to the control group. Furthermore, intakes of 251 
individual flavanones (naringenin, eriodictyol, and hesperetin, P<0.05), a flavone (luteolin, P<0.05), 252 
and isoflavones (daidzein and genistein, P<0.01) were higher in the DG group compared to the control 253 
group at endpoint. With regards to lignans, phenolic acids and stilbenes classes, there were higher 254 
intakes of secoisolariciresinol (P<0.05), matairesinol (P<0.001), protocatechuic acid (P<0.01), vanillic 255 
acid (P<0.001), 4-hydroxybenzoic acid (P<0.001), syringic acid (P<0.001), p-coumaric acid (P<0.001) 256 
and ferulic acid (P<0.05) at endpoint in the DG group compared to the control group. There were no 257 
differences between groups in individual flavonols (including kaempferol, quercetin, myricetin and 258 
isorhamnetin) nor flavanols (including individual catechins and theaflavins). 259 
The main sources of total polyphenols at endpoint in both groups were tea, coffee & wine (control; 260 
61%, DG; 59%), fruits (control; 10%, DG; 17%) and fruit juices (control; 8%, DG; 4%) (Figure 2). 261 
Main sources of flavonoids in control and DG groups were tea, coffee & wine (control; 55%, DG; 262 
55%), fruits (control; 14%, DG; 21%) and fruit juices (control; 10%, DG; 5%). Main sources of the 263 
flavanols subclass were tea, coffee & wine (control; 64%, DG; 65%), fruits (control; 13%, DG; 19%) 264 
and chocolates (control; 11%, DG; 4%). There was an increase in the percentage of polyphenols 265 
sourced by fruits, cereal products (breakfast cereal and cereal bar) and nuts & seeds (see Figure 3 for 266 
further details) in the group following the DG diet compared to baseline. There was a decrease in 267 
percentage of polyphenols derived from less recommended food options as fruit juices, chocolates and 268 
biscuits (Figure 3).    269 
Food frequency questionnaire  270 
There were no differences in total flavonoids and flavonoid subclass estimated intakes between groups 271 
at baseline. At endpoint the DG group reported higher intakes of total flavonoids, total anthocyanidins, 272 
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total flavones, total flavanols, and total proanthocyanidins (Table 3). Flavanone and flavonol intakes 273 
did not differ between groups at endpoint. Differences between individual polyphenol components 274 
revealed higher reported intakes of cyanidin, delphinidin, petunidin and peonidin (P<0.001), malvidin 275 
and pelargonidin (P<0.005), catechin (P<0.01), and epicatechin-3-O-gallate, epigallocatechin-3-O-276 
gallate, myricetin and luteolin (P<0.05) in the DG group (data not shown) compared to control.   277 
 Urinary polyphenol excretion  278 
The ten aglycones quantified in urine were either metabolites of parent glucuronide/sulphated 279 
compounds formed in human tissues, or metabolites produced by the gut microbiota, e.g. enterolactone 280 
from lignans present in fibre-rich food. At endpoint there was a greater 24 h urinary excretion of 281 
phloretin, eriodictyol, hesperetin, luteolin, quercetin, gallic acid, vanillic acid and enterolactone in the 282 
DG group compared to the control group (Table 4), and a non-significant tendency towards a similar 283 
response for daidzein excretion. Daidzein was not detected in 37 participants of the 91 subsample, 284 
which could contribute to the lack of significance in the results given that values observed are 285 
considerably higher in the intervention group. The only polyphenol that was excreted in similar 286 
amounts in both dietary groups was epicatechin. 287 
Discussion  288 
The aim of this secondary analysis of dietary intake data from the CRESSIDA trial was to investigate 289 
whether following advice to adhere to UK dietary guidelines increased polyphenol intakes. Baseline 290 
polyphenol/flavonoid intakes from 4-DFD and FFQ were in alignment with previous reports in UK 291 
populations using 24 h recall(27, 28, 29, 30, 31, 65, 66, 67) or FFQ(15). The hypothesis was supported by the 292 
finding that total estimated polyphenol intakes were approximately 200 mg per 10 MJ energy intake 293 
higher at endpoint in the DG group compared to the control group. However, estimates of total 294 
polyphenol intakes are only as accurate as the polyphenol composition data, and rely on the sum of the 295 
components, which may lead to underestimates if complete composition profile data are unavailable for 296 
individual foods. Therefore, total polyphenol intake data should be interpreted in the context of the 297 
individual polyphenol intakes. Estimated dietary intakes by 4-DFD showed that the DG group had 298 
higher intakes of individual polyphenols/phenolic acids where main food sources were fruits and 299 
vegetables (cyanidin, malvidin, peonidin, petunidin, protocatechuic acid, naringenin, eriodictyol, 300 
hesperetin and syringic acid), nuts and seeds (secoisolariciresinol and matairesinol) and soy products 301 
(daidzein, genistein and other isoflavonoids) compared to the control group. In agreement with the 4-302 
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DFD results, FFQ estimates of total flavonoids, proanthocyanidins and anthocyanidins were higher in 303 
the DG group compared to the control group. Ten representative aglycone polyphenols and phenolic 304 
acids (from glucuronidated and sulphated metabolites) were measured in 24 h urine samples collected 305 
concurrently with 4-DFD as objective biomarkers of (poly)phenol intakes, in order to determine the 306 
accuracy of the dietary intake estimates. The ability to discriminate between the dietary group 307 
subsamples was consistent with 4-DFD, except for epicatechin, daidzein and quercetin where there 308 
were no significant differences in urinary excretion in contrast with higher estimated intakes in the DG 309 
group by 4-DFD. Both the 4-DFD and urinary biomarker methods agreed that intakes of 310 
phlorizin/phloretin, eriodictyol, hesperidin, luteolin, vanillic acid and lignans/enterolactone were 311 
greater in the DG group.  312 
The ability to discriminate between dietary intervention groups supports the utility of 4-DFD and 313 
urinary metabolites for assessment of dihydrochalcones, flavanones, flavones, hydroxybenzoic acids 314 
and lignan intakes over short-term periods. Differing findings may be due to incomplete phenolic 315 
composition data, the well-known inaccuracies of self-reported dietary assessment methodology(68, 69), 316 
and the inter-individual variability in absorption and metabolism(8, 70) or incomplete deconjugation of 317 
sulphated/glucuronidated metabolites(71) reflected in the urinary biomarkers. Urine polyphenol 318 
concentrations may also be the sum product of endogenous metabolism and dietary intakes. For 319 
example, gallic acid is a common metabolite of black tea theaflavins and thearubigins(72, 73), therefore 320 
its urinary excretion could reflect the consumption of such beverage combined with foods providing 321 
gallic acid per se. Vanillic acid can be found in high concentrations in foods consumed in small 322 
quantities such as herbs; also in moderate concentration in dates, olives and cranberries and in low 323 
concentrations in foods more frequently consumed like oats and rice(39). It is also a common metabolite 324 
of anthocyanins(74, 75), and so variability in urinary vanillic acid excretion could reflect varying intakes 325 
of both vanillic acid and anthocyanin-rich foods, therefore it is likely that the increased urinary 326 
excretion at endpoint mainly represents intake of foods rich in anthocyanins rather than vanillic acid. 327 
Vanillic acid is also reported to be present in urine after consumption of black tea(76) and dark 328 
chocolate(77); however, intakes of black tea and dark chocolate were not higher in the DG group at 329 
endpoint, and therefore are unlikely to account for the increased urinary excretion and reported intakes 330 
in the 4-DFD. Enterolactone is the main colonic metabolite of lignans, which are phytoestrogenic 331 
compounds present in high concentrations in vegetables, cereals and grain products, seeds, nuts and 332 
berries and other fruits(65, 78). These urinary excretion data are in agreement with previous 333 
epidemiologial studies(79), supplementation studies where known doses of polyphenols were 334 
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administrated(44, 80), in RCTs aiming to increase flavonid-rich fruit and vegetables intake(81) and with 335 
population under free-living conditions(43). Polyphenol urinary excretion has shown to be an useful 336 
biomarker of fruit and vegetables intakes, capable of detecting even small changes in studies under 337 
controlled diets(45, 82, 83). 338 
Following dietary guidelines did lead to increases in specific polyphenols that have been associated 339 
with health benefits (e.g. anthocyanins, flavanones, isoflavones, phenolic acids and lignans(84, 85, 86, 87). 340 
This suggests that consuming at least 5 portions F&V per day and >50 % of cereal intake as wholegrain 341 
will lead to an enrichment in dietary polyphenol profiles above and beyond the large amounts of 342 
polyphenols supplied by beverages. In particular, estimated anthocyanidin intakes were augmented by 343 
following dietary guidelines which may confer a reduction in risk of T2D(25), and acute reductions in 344 
postprandial glycaemia(88, 89, 90,91). The dietary intake results reported here are consistent with the theory 345 
that greater intakes of specific polyphenols may contribute to the protective effects of a diet rich in 346 
fruits and vegetables and wholegrain cereals, alongside greater dietary intakes of nutrients and other 347 
non-nutrient bioactives, e.g. potassium, vitamin C, soluble fibre, carotenoids and glucosinolates. 348 
However, our results confirm(29, 30, 31) that food groups that are recommended by UK government as 349 
part of the Eatwell Guide – fruits and vegetables, wholegrain cereals, beans, pulses, nuts and seeds - 350 
contribute a much smaller proportion of daily polyphenol intakes in a UK population compared to 351 
commonly consumed beverages, even when that population is following dietary guidelines. Analysis of 352 
dietary data showed no group differences in (poly)phenol intakes (by 4-DFD) where main food sources 353 
were not targets for UK dietary guidelines such as tea (catechins, theaflavins, proanthocyanidins, 354 
quercetin) and wine (stilbenes, proanthocyanidins). However, the sources of these polyphenols may 355 
have differed between groups; for example, the DG group reported lower intakes of stilbenes from 356 
wine and increased intakes of stilbenes from fruit.  357 
The relative impacts of total and specific (poly)phenol intakes on risk of CVD and type 2 358 
diabetes requires investigation. Clearly there is only limited scope for increasing total polyphenol 359 
intake by following dietary guidelines – an approximate increase of 200 mg per day per 10 MJ energy 360 
intake. The extent to which this is relevant to cardio-metabolic health is currently unclear due to the 361 
lack of robust evidence for the relative impact of different polyphenol subclasses on risk factors for 362 
CVD and type 2 diabetes. Although the evidence is currently insufficient, it is plausible to hypothesize 363 
that in the future there may be consensus that tea and coffee (poly)phenols(92, 93) may have some of the 364 
strongest cardio-metabolic protective effects amongst all dietary phenolics, so that due to the large 365 
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amounts of tea and coffee consumed at a population level, the gain to health in consuming at least 5 366 
portions/day of fruits and vegetables and choosing wholegrain sources of starchy carbohydrates is 367 
likely to be due to other nutritional factors. Conversely, future advances in nutritional science may one 368 
day demonstrate that certain polyphenols specific to fruits, vegetables or wholegrain cereals have 369 
particularly potent bioactivity in preventing inflammation, atherosclerosis or insulin resistance, which 370 
would bring about a departure from the prevailing approach of considering all plant chemicals that 371 
contain a similar chemical structure in the same way. There has been some debate around whether 372 
establishing dietary reference intakes (DRI) for polyphenols could be beneficial; with suggested 373 
approaches including recommendations for polyphenol-rich F&V (5-a-day)(52), establishing a specific 374 
daily dose for a given effect(54) or establishing values to improve health or prevent disease risk in 375 
different life stages(53). Further research is required to provide robust interventional evidence for any 376 
refinement to current “5-a-day” guidelines, since the relative health impact of a multitude of other non-377 
nutrient bioactives and the complex array of plant cell wall polysaccharides, resistant starch and 378 
oligosaccharides (collectively known as fibre) contained in low-polyphenol plant-based foods is only 379 
partially understood. Furthermore, in the light of the fact that NDNS survey data suggest that the UK 380 
population are not meeting current recommendations for F&V then it would be futile, and possibly 381 
counter-productive, to add further complexity to existing public health dietary advice. 382 
The validation of adequate biomarkers of dietary intake, of exposure to dietary components and 383 
of compliance to dietary interventions has been a focus of investigation for many years(94) and the 384 
identification of polyphenol intake biomarkers is no exception(83, 95). Assessment of compliance in 385 
dietary intervention studies with fruits and vegetables has been done by validated biomarkers(96) such as 386 
vitamin C, carotenoids and potassium, however polyphenol excretion in urine may be used to assess 387 
flavonoid-rich dietary interventions(81) or specific fruit and vegetable intakes, for example phloretin for 388 
apple intake and naringenin and hesperetin for citrus fruit(95, 97). Given the importance of accurate 389 
assessment of polyphenol intake in order to link it with beneficial effects on health(98), the ability to 390 
detect the amount consumed represents a challenge in epidemiological and clinical studies.  391 
The bespoke food composition table developed for the 4-DFD polyphenol analysis in the 392 
present study included the estimation of 52 individual compounds and contained 1141 foods 393 
representative of an average UK diet as well as some of the most commonly eaten food from non-394 
traditional UK cuisine as Turkish, Indian, Italian, Chinese, Japanese, and others. This food composition 395 
table could be used as a basis for future studies analysing diet patterns in the UK population, comparing 396 
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polyphenols intake and/or linking intake with health benefits, although it would require a significant 397 
staff cost commitment to maintain and update with new recipes and new versions of Phenol Explorer 398 
over time. Although an onerous process, the creation of a bespoke food composition table for 399 
polyphenol analysis in a specific population seems to be the most effective way to obtain an accurate 400 
estimation of polyphenol intake. Although the FFQ is a valid and reliable dietary assessment tool for 401 
estimation of habitual intake in populations, it has limitations in the way that it can collect information, 402 
since it is based on uniform estimated portion sizes and is semi-quantitative. Dietary intake of total 403 
flavonoid intake, six flavonoid subclasses and 32 individual flavonoids (aglycones) were estimated by 404 
FFQ (EPIC-Norfolk) using methodology previously applied in large cohort studies(15, 17, 23, 25, 26,  99). The 405 
EPIC-Norfolk FFQ, although validated for whole foods intake(100), has not been validated for flavonoid 406 
intake. Methodological barriers of this approach in regard to flavonoid estimation are particularly 407 
limiting in smaller study cohorts: some foods are grouped incongruously with regards to their flavonoid 408 
composition such as “strawberries, raspberries and kiwi”, or “peaches, plums and apricots” and “wine” 409 
(no separation of red, white and rosé). Some important flavonoid sources are missing such as 410 
blueberries, soy beverages, and lemon, among others. The inadequacy of this method could lead to 411 
under- or overestimation of flavonoid intakes. Studies have used food diaries for estimation of flavanol 412 
intake in European populations(29), isoflavone and lignan intakes(66) and 20 subclasses of 413 
polyphenols(31) in a UK population, each one creating their own food composition table for polyphenol 414 
analysis, however they have not included objective biomarkers for corroborating agreement between 415 
methods. More specialised questionnaires for intake estimation have been developed for individual 416 
compounds like quercetin and naringenin (101), flavonoid subclasses such as flavonols and flavones in a 417 
Chinese population(102), complete flavonoid class in Australian population(34) and Flemish 418 
population(103). In summary, although the FFQ results reported here were in broad agreement with the 419 
4-DFD regarding the discernment of differences in total flavonoid intakes in a dietary intervention 420 
study, future research in this area could include the development of a specific FFQ, validated in a UK 421 
population, for estimation of phenolic intakes including all classes and main subclasses as were 422 
estimated by 4-DFD in this study.  423 
Limitations in the present study include the hydrolysis of urinary polyphenols by 424 
glucoronidase/sulphatase enzymes prior to analysis, which could compromise the stability of 425 
polyphenols that are to be quantified (104, 105). Glucoronidase/sulphatase enzymes may fail to completely 426 
hydrolyse all sulphated and methylated-sulphated metabolites, which may have been compounded by 427 
the addition of boric acid as a preservative to prevent yeast growth, and therefore urinary excretion of 428 
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the corresponding aglycone could be underestimated(71). Furthermore, our approach required 429 
preselection of polyphenols to be analysed which means that many other polyphenols present in 24 h 430 
urine that may have also functioned as biomarkers of intake were not detected and quantified. Although 431 
reported anthocyanidin intakes were greater in the DG group, we did not attempt to analyse 432 
anthocyanins in urine as they have low recovery as parent compounds and only weak correlations with 433 
dose ingested, necessitating the use of stable isotopes to accurately measure the excretion of 434 
anthocyanin metabolites(44). The 4-DFD proved to be an accurate approach for estimate of short-term 435 
polyphenol intake, however, serious consideration must be made of the potential researcher burden and 436 
cost if using these methods in larger scale studies, particularly where a simple indicator of compliance 437 
to dietary advice is required.  438 
 
Strengths of our study include the fact that the data collected in this study enabled a comparison of two 439 
dietary assessment methods with objective biomarkers of (poly)phenol dietary intake collected 440 
concurrently towards the end of the dietary intervention period. To date, this 3-way comparison has 441 
only been reported previously in a cross-sectional(106) study using a crude estimate of total urinary 442 
polyphenol excretion by the Folin-Ciocalteu assay. To the best of our knowledge this is the first study 443 
to use the 3 way comparison on data obtained from an RCT allowing comparison of change from 444 
baseline for individuals advised to consume a diet consistent with dietary guidelines.  445 
In conclusion, participants following advice to adhere to UK dietary guidelines consumed a greater 446 
amount of total polyphenols than a control group consuming a representative UK diet. In particular, 447 
intakes of individual polyphenols that are mainly sourced from fruits and vegetables, nuts, seeds and 448 
soy products were increased in the DG group. The results of this study advance the field of polyphenol 449 
research as they demonstrate that a diet consistent with dietary guidelines is also moderately richer in 450 
polyphenols compared to a typical UK dietary pattern, despite the relatively high baseline intakes 451 
derived from commonly consumed beverages such as tea and coffee. In addition to increased intakes of 452 
dietary fibre and certain micronutrients, replacement of saturated fatty acids with unsaturated fatty 453 
acids, and lower salt and free sugars, following dietary guidelines will also increase polyphenol intakes 454 
which may contribute to the overall reduction in risk factors for cardiometabolic diseases. 455 
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62. Achaintre D, Buleté A, Cren-Olivé C et al. (2016) Differential isotope labeling of 38 dietary 
polyphenols and their quantification in urine by liquid chromatography electrospray ionization tandem 
mass spectrometry. Anal Chem 88, 2637-2644. 
63. Bingham S, Cummings JH (1983) The use of 4-aminobenzoic acid as a marker to validate the 
completeness of 24 h urine collections in man. Clin Sci 64, 629-635. 
64. Rhee JJ, Sampson L, Cho E et al. (2014) Comparison of methods to account for implausible 
reporting of energy intake in epidemiologic studies. Am J Epidemiol 181, 225-233. 
65. Tetens I, Turrini A, Tapanainen H et al. Dietary intake and main sources of plant lignans in five 
European countries. Food Nutr Res. Published online: 11 June 2013. doi: 10.3402/fnr.v57i0.19805. 
66. Mulligan AA, Kuhnle GG, Lentjes MA et al. (2013) Intakes and sources of isoflavones, lignans, 
enterolignans, coumestrol and soya-containing foods in the Norfolk arm of the European Prospective 
Investigation into Cancer and Nutrition (EPIC-Norfolk), from 7 d food diaries, using a newly updated 
database. Public Health Nutr 16, 1454-1462. 
67. Knaze V, Zamora-Ros R, Lujan-Barroso L et al. (2012) Intake estimation of total and individual 
flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr 108, 1095-1108. 
68. Bingham SA GC, Welch A, Day K, Cassidy A, Khaw K T, Sneyd MJ, Key TJA, Roe L and Day 
NE. (1994) Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 
24h recalls, food frequency questionnaires and estimated diet records. B J Nut 72, 619-642. 
69. Zamora-Ros R, Rabassa M, Llorach R et al. (2012) Application of Dietary Phenolic Biomarkers in 
Epidemiology: Past, Present, and Future. J Agric Food Chem 60, 6648–6657. 
70. Chen Z, Zheng S, Li L et al. (2014) Metabolism of flavonoids in human: A comprenhensive 
review. Current Drug Metabolism 15, 48-61. 
71. Saha S, Hollands W, Needs PW, Ostertag LM, de Roos B, Duthie GG and Kroon PA (2012) 
Human O-sulfated metabolites of (−)-epicatechin and methyl-(−)-epicatechin are poor substrates for 
commercial aryl-sulfatases: Implications for studies concerned with quantifying epicatechin 
bioavailability. Pharmacol Res 65, 592-602. 
72. Henning SM, Wang P, Abgaryan N et al. (2013) Phenolic acid concentrations in plasma and urine 
from men consuming green or black tea and potential chemopreventive properties for colon cancer. 
Mol Nutr Food Res 57, 483-493. 
73. Crozier A, Clifford MN, Del rio D (2012) Bioavalability of dietary monomeric and polymeric 
flavan-3-ols. In Flavonoids and related compounds, pp. 45-78 [Spencer JPE and Crozier A, editors]. 
Boca Raton, FL.: CRC Press. 
74. Nurmi T, Mursu J, Heinonen M et al. (2009) Metabolism of berry anthocyanins to phenolic acids in 
humans. J Agric Food Chem 57, 2274-2281. 
75. de Ferrars RM, Cassidy A, Curtis P et al. (2013) Phenolic metabolites of anthocyanins following a 
dietary intervention study in post-menopausal women. Mol Nutr Food Res 58,490-502. 
76. Olthof MR, Hollman PC, Buijsman MN et al. (2003) Chlorogenic acid, quercetin-3-rutinoside and 
black tea phenols are extensively metabolized in humans. J Nutr 133, 1806-1814. 
77. Rios LY, Gonthier MP, Remesy C et al. (2003) Chocolate intake increases urinary excretion of 
polyphenol-derived phenolic acids in healthy human subjects. Am J Clin Nutr 77, 912-918. 
78. Pounis G, Di Castelnuovo A, Bonaccio M et al. (2016) Flavonoid and lignan intake in a 
Mediterranean population: proposal for a holistic approach in polyphenol dietary analysis, the Moli-
sani Study. Eur J Clin Nutr 70, 338-345. 
79. Valls-Pedret C, Lamuela-Raventos RM, Medina-Remon A et al. (2012) Polyphenol-rich foods in 
the Mediterranean diet are associated with better cognitive function in elderly subjects at high 
cardiovascular risk. J Alzheimers Dis 29, 773-782. 
23 
 
80. Shi Y, Williamson G (2015) Comparison of the urinary excretion of quercetin glycosides from red 
onion and aglycone from dietary supplements in healthy subjects: a randomized, single-blinded, cross-
over study. Food Funct 6, 1443-1448. 
81. Chong MF, George TW, Alimbetov D et al. (2012) Impact of the quantity and flavonoid content of 
fruits and vegetables on markers of intake in adults with an increased risk of cardiovascular disease: the 
FLAVURS trial. Eur J Nutr 52, 361-78 
82. Brevik A, Rasmussen SE, Drevon CA et al. (2004) Urinary excretion of flavonoids reflects even 
small changes in the dietary intake of fruits and vegetables. Cancer Epidemiol Biomarkers Prev 13, 
843-849. 
83. Vetrani C, Rivellese AA, Annuzzi G et al. (2014) Phenolic metabolites as compliance biomarker 
for polyphenol intake in a randomized controlled human intervention. Food Res Int 63, 233-238. 
84. Garcia-Conesa MT, Chambers K, Combet E et al. Meta-analysis of the effects of foods and derived 
products containing ellagitannins and anthocyanins on cardiometabolic biomarkers: analysis of factors 
influencing variability of the individual responses. Int J Mol Sci. Published online: 19 February 2018. 
doi: 10.3390/ijms19030694. 
85. Rienks J, Barbaresko J, Nothlings U (2017) Association of isoflavone biomarkers with risk of 
chronic disease and mortality: a systematic review and meta-analysis of observational studies. Nutr Rev 
75, 616-641. 
86. Onakpoya IJ, Spencer EA, Thompson MJ et al. (2015) The effect of chlorogenic acid on blood 
pressure: a systematic review and meta-analysis of randomized clinical trials. J Hum Hypertens 29, 77-
81. 
87. Testai L, Calderone V. Nutraceutical Value of Citrus Flavanones and Their Implications in 
Cardiovascular Disease. Nutrients. Published online: 16 May 2017 May. doi: 10.3390/nu9050502.  
88. Törrönen R, Kolehmainen M, Sarkkinen E et al. (2012) Postprandial glucose, insulin, and free fatty 
acid responses to sucrose consumed with blackcurrants and lingonberries in healthy women. Am J Clin 
Nutr 96, 527-533. 
89. Törrönen R, Sarkkinen E, Niskanen T et al. (2012) Postprandial glucose, insulin and glucagon-like 
peptide 1 responses to sucrose ingested with berries in healthy subjects. Br J Nutr 107, 1445-1451. 
90. Törrönen R, Sarkkinen E, Tapola N et al. (2010) Berries modify the postprandial plasma glucose 
response to sucrose in healthy subjects. Br J Nutr 103, 1094-1097. 
91. Castro-Acosta ML, Smith L, Miller RJ et al. (2016) Drinks containing anthocyanin-rich 
blackcurrant extract decrease postprandial blood glucose, insulin and incretin concentrations. J Nutr 
Biochem 38, 154-161. 
92. Hartley L, Flowers N, Holmes J et al. Green and black tea for the primary prevention of 
cardiovascular disease. Cochrane Database Syst Rev. Published online:18 june 2013 doi: 
10.1002/14651858.CD009934.pub2.  
93. Tajik N, Tajik M, Mack I et al. (2017) The potential effects of chlorogenic acid, the main phenolic 
components in coffee, on health: a comprehensive review of the literature. Eur J Nutr 56, 2215-2244. 
94. Dragsted LO, Gao Q, Pratico G et al. Dietary and health biomarkers-time for an update. Genes 
Nutr. Published online: 29 September 2017. doi: 10.1186/s12263-017-0578-y.  
95. Noh H, Freisling H, Assi N et al. Identification of urinary polyphenol metabolite patterns 
associated with polyphenol-rich food intake in adults from four european countries. Nutrients. 
Published online: 25 July 2017. doi: 10.3390/nu9080796. 
96. Woodside JV, Draper J, Lloyd A et al. (2017) Use of biomarkers to assess fruit and vegetable 
intake. Proc Nutr Soc 76, 308-315. 
97. Brouwer-Brolsma EM, Brennan L, Drevon CA et al. (2017) Combining traditional dietary 
assessment methods with novel metabolomics techniques: present efforts by the Food Biomarker 
Alliance. Proc Nutr Soc 76, 619-627. 
24 
 
98. Kuhnle GG (2012) Nutritional biomarkers for objective dietary assessment. J Sci Food Agric 92, 
1145-1149. 
99. Cassidy A, O'Reilly EJ, Kay C et al. (2011) Habitual intake of flavonoid subclasses and incident 
hypertension in adults. Am J Clin Nutr 93, 338-347. 
100. McKeown NM, Day NE, Welch AA et al. (2001) Use of biological markers to validate self-
reported dietary intake in a random sample of the European Prospective Investigation into Cancer 
United Kingdom Norfolk cohort. Am J Clin Nutr 74, 188-196. 
101. Ranka S, Gee JM, Biro L et al. (2008) Development of a food frequency questionnaire for the 
assessment of quercetin and naringenin intake. Eur J Clin Nutr 62, 1131-1138. 
102. Zhang Y, Cao J, Chen W et al. (2010) Reproducibility and relative validity of a food frequency 
questionnaire to assess intake of dietary flavonol and flavone in Chinese university campus population. 
Nutr Res 30, 520-526. 
103. Mullie P, Clarys P, Deriemaeker P et al. (2007) Estimation of daily human intake of food 
flavonoids. Plant Foods Hum Nutr 62, 93-98. 
104. Cheynier V, Tomas-Barberan FA, Yoshida K (2015) Polyphenols: From Plants to a Variety of 
Food and Nonfood Uses. J Agric Food Chem 63, 7589-7594. 
105. Ding Y, Peng M, Zhang T et al. (2013) Quantification of conjugated metabolites of drugs in 
biological matrices after the hydrolysis with β-glucuronidase and sufatase: a review of bio-analytical 
methods. Biomed Chromatogr 27, 1280-1295. 
106. Burkholder-Cooley NM, Rajaram SS, Haddad EH et al. (2017) Validating polyphenol intake 
estimates from a food-frequency questionnaire by using repeated 24-h dietary recalls and a unique 
method-of-triads approach with 2 biomarkers. Am J Clin Nutr 105, 685-694. 
  
25 
 
Figure legends 
Figure 1 Flow of participants through the CRESSIDA study 
Figure 2 Main polyphenol food sources in control and dietary guidelines groups, at endpoint, of the 
CRESSIDA study as estimated by four-day food diary 
Figure 3 Percentage changes from baseline in main food group sources of polyphenols in dietary 
guidelines group as estimated by four-day food diary 
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Table 1 Baseline characteristics of the CRESSIDA study population by randomised group  
Characteristic 
Control 
(n=82) 
Dietary Guidelines 
(n=79) 
Difference 
between groups 
(P* value) 
Gender (n)      
Female  50 47  
Male 32 32  
 Mean SD Mean SD  
Age (years) 52 8.0 53 8.0 0.717 
BMI (kg/m2) 26.8 3.9 25.4 3.7 0.019 
Waist circumference (cm)      
Female/male 91.9/98.2 10.0/12.2 87.1/97.3 12.2/9.3 0.093 
SBP (mmHg) 122.0 11.5 121.6 14.3 0.848 
DBP  (mmHg) 73.9 7.1 73.8 8.0 0.930 
Glucose (mmol/L) 5.0 0.4 5.3 0.5 0.990 
Total cholesterol (mmol/L) 5.3 0.9 5.4 1.1 0.983 
TC:HDL cholesterol ratio 3.6 1.0 3.5 1.0 0.262 
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure.  
*Statistical comparisons between groups at baseline by independent T-test or independent 
samples Mann-Whitney U-test. 
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Table 2 Daily intake of polyphenols estimated by four-day food diary and adjusted for energy intake following dietary guidelines and 
control diets.  
Polyphenols (mg/d/10 MJ) 
Classes and subclasses 
Baseline (n=161) 
Endpoint (n=161) Differences 
between groups 
at endpoint (P‡)                Control (n=82) Dietary Guidelines (n=79) 
Total polyphenols*  1202† (1093, 1323) 1084 (980, 1197) 1279 (1158, 1412) 0.023§ 
Flavonoids 840† (536, 1263) 802 (456, 1109) 882 (610, 1401) 0.014 
Anthocyanidins 55 (14, 130) 30 (14, 108) 76 (25, 144) 0.032 
Dihydrochalcones 1.6 (0.0, 3.8) 2 (0, 4) 2 (1, 6) 0.297 
Flavanols 349 (114, 526) 311 (104, 498) 394 (128, 665) 0.159 
Proanthocyanidins 231†  (117, 339) 195 (115, 324) 249 (169, 381) 0.020 
Flavanones 31 (4, 64) 24 (2, 58) 33 (8, 84) 0.096 
Flavones 6 (3, 12) 5 (1, 12) 5 (2, 12) 0.603 
Flavonols 80 (51, 112) 80 (50, 105) 83 (58, 127) 0.125 
Isoflavones 0.3 (0.1, 9.9) 0.1 (0.1, 0.4) 0.5 (0.1, 65.0) 0.002 
Lignans 0.5 (0.2, 5.0) 0.3 (0.1, 0.4) 0.5 (0.2, 6.0) <0.001 
Phenolic acids 289 (185, 569) 221 (132, 493) 344 (209, 522) 0.012 
Hydroxybenzoic acids 90 (35, 143) 75 (32, 125) 100 (55, 170) 0.067 
Hydroxycinnamic acids 149 (88, 450)  119 (59, 378) 172  (99, 444) 0.018 
Stilbenes 0.09 (0.02, 0.71) 0.09 (0.02, 0.94) 0.26 (0.07, 1.25) 0.042 
Other polyphenols 21 (11, 41) 13 (6, 30) 37 (20, 58) <0.001 
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All values are medians (with lower and upper limits of IQR), except where * denotes values are geometric means (95% CI), 
adjusted for baseline and gender at endpoint. 
†Statistically significant differences between groups at baseline by independent T-test (total polyphenols) or independent 
samples Mann-Whitney U-test (all other comparisons); intakes were higher in the DG group than the control group, P<0.05. 
‡Statistical comparisons between groups at endpoint by Mann-Whitney U-test, except where § denotes statistical comparisons 
between groups at endpoint adjusted for baseline and gender by ANCOVA. 
 
 
 
 
Table 3 Median daily intake of flavonoids estimated by food frequency questionnaire in dietary guidelines and control groups 
Flavonoids (mg/d) 
Class and subclasses 
Baseline (n=161) 
Endpoint (n=161) Differences 
between groups 
at endpoint (P*) 
                   Control (82) Dietary Guidelines (79) 
Total flavonoids 661 (417, 867) 539 (350, 862) 715 (571, 906) 0.005 
Anthocyanidins 19 (10, 35) 16 (9, 31) 32 (19, 50) <0.001 
Flavones  2.4 (1.6, 3.5) 2.7 (1.5, 3.7) 3.2 (2.0, 4.4) 0.013 
Flavonols  35 (23, 47) 39 (21, 54) 39 (31, 50) 0.199 
Flavanols 90 (40, 143) 85 (35, 146) 97 (80, 143) 0.048 
Flavanones 23 (8, 42) 25 (10, 43) 27 (8, 49) 0.352 
Proanthocyanidins  265 (184, 379) 232 (184, 371) 290 (229, 385) 0.021 
Values are medians (lower and upper limits of the IQR). There were no significant differences between groups at baseline. 
* Statistical comparisons between groups at endpoint by Mann-Whitney U-test.
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Table 4 Comparison of urinary phenolic excretion method and polyphenol intake estimated by 4-day food diary in their ability to 
discriminate between subsample populations either adhering to dietary guidelines or a control diet. 
Polyphenols 
Urinary excretion† (µmol/d) Dietary intake (mg/d/10 MJ) 
Control (n=46) 
Dietary Guidelines 
(n=45) 
Difference 
between 
groups (P) 
Control (n=46) 
Dietary Guidelines 
(n=45) 
Difference 
between 
groups (P) 
Phloretin‡ 0.09 (0.01, 0.28) 0.40* (0.18, 0.97) <0.001 1.2 (0.0, 3.5) 3.1* (1.1, 5.9) 0.006 
Epicatechin 0.45 (0.24, 0.60) 0.44 (0.21, 0.70) 0.943 30 (15, 50) 40* (29, 67) 0.013 
Eriodictyol 0.25 (0.09, 0.43) 0.51* (0.20, 0.86) 0.011 0.00 (0.00, 0.02) 0.02* (0.01, 0.06) <0.001 
Hesperetin 0.20 (0.00, 2.03) 1.38* (0.09, 3.51) 0.010 8 (1, 23) 17* (4, 35) 0.019 
Luteolin 1.8 (0.9, 2.9) 2.7* (1.5, 3.7) 0.017 0.5 (0.3, -8) 1.5* (0.9, 3.3) <0.001 
Quercetin 4.7 (1.5, 7.4) 6.6 (2.4, 12.8) 0.105 50 (27, 66) 59* (41, 85) 0.028 
Daidzein 0.02 (0.00, 0.40) 0.11 (0.00, 0.80) 0.074 0.04 (0.04, 0.10) 3.5* (0.02, 21.2) 0.006 
Gallic acid 0.7 (0.2, 2.0) 1.4 (0.5, 3.6) 0.053 62 (18, 107) 90 (23, 153) 0.134 
Vanillic acid 1.4 (0.2, 2.6) 3.0* (0.9, 5.9) 0.023 0.2 (0.1, 0.2) 0.4* (0.2, 0.6) <0.001 
Lignan/ 
Enterolactone§ 
5.7 (2.1, 10.6) 10.1* (3.8, 22.6) 0.010 0.2 (0.1, 0.4) 0.6* (0.3, 6.1) <0.001 
Excretion of polyphenols in 24 h urine and dietary intake of the direct dietary precursor estimated by 4-DFD at endpoint in a subsample of the 
CRESSIDA study population selected for the lowest (control group) and highest (dietary guidelines group) fruit and vegetables intake using 
self-reported data from food frequency questionnaires (n=91).  
All values are median (lower and upper limits of IQR). All between group comparisons were carried out by independent samples Mann-
Whitney U Test. 
† Values adjusted for 24 h urine volume. 
‡ Sum of phloretin and phlorizin  
§ Intake of lignans was used as direct dietary precursor of enterolactone. 
*Statistically significant differences between groups at endpoint, P<0.05. 
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